Tetrabenazine Tablet
Product Images NDC 27241-177

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 27241-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12.5mg (Tetrabenazine 12 5)

Label for Tetrabenazine Tablets 12.5 mg, oral tablets packaged as 112 tablets, marketed by Ajanta Pharma USA Inc. The label includes storage instructions, dispensing guidance, a warning to keep out of reach of children, and states the product is made in India. It also features the NDC 27241-176-13, a barcode, and an Rx Only symbol.*

FDA Label Image

25mg (Tetrabenazine 25mg)

Tetrabenazine Tablets 25 mg label for a prescription oral tablet product. The label states each tablet contains 25 mg tetrabenazine and indicates a count of 112 tablets. It includes storage instructions, a child-resistant warning, and directs pharmacists to dispense the medication guide. Marketed by Ajanta Pharma USA Inc., made in India. The label features an Rx Only symbol and a barcode.*

FDA Label Image

Figure1 (Tetrabenazine Figure1)

A line graph showing change in chorea scores over a 14-week study, comparing Tetrabenazine and placebo groups. The x-axis represents study weeks, and the y-axis shows chorea score change. Tetrabenazine group data points are connected with a solid line, placebo with a dashed line. Error bars represent standard error of the mean. Numeric sample sizes for each group are noted at multiple weeks. A 'Washout' period is marked at week 13.*

FDA Label Image

Figure2 (Tetrabenazine Figure2)

A cumulative percentage plot comparing Tetrabenazine and placebo groups in change from baseline in chorea score. The x-axis shows changes from -16 to +6 points, and the y-axis shows cumulative percentage of patients from 0% to 100%. The graph includes vertical markers at 10, 6, and 3 points. Data table shows percentages of patients achieving scores of -10, -6, and -3 for Tetrabenazine and placebo treatment groups.*

FDA Label Image

Structure (Tetrabenazine Structure)

Chemical structure diagram of tetrabenazine, showing its molecular framework including methoxy groups, a ketone, and a substituted aliphatic chain. The diagram represents the active ingredient tetrabenazine used in oral tablet dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.